Aim Methotrexate has demonstrated efficacy in treating ectopic pregnancies. This study
explores factors influencing treatment success, focusing on laboratory and ultrasonographic …

Objective This study assessed the relevance of reductions in beta-hCG levels between days
0 and 4 and between days 0 and 7 after single-dose methotrexate therapy, and the success …

Objective: To investigate the relationship of beta-hCG changes between the first, fourth and
seventh days as a predictor of the additional dose requirement in single-dose methotrexate …

Introduction This study's aim is to investigate whether the rise in β-hCG levels between days
0-4 in patients with tubal ectopic pregnancy who have received a single dose of …

Objective To investigate the systemic immune‐inflammation index (SII) and neutrophil‐to‐
lymphocyte ratio (NLR) in predicting a successful methotrexate response in tubal ectopic …

Aim The single-dose methotrexate (MTX) regimen is effective and minimizes side effects but
an additional second dose is needed in case of failure in an ectopic pregnancy (EP). We …

Background. Serum beta-human chorionic gonadotropin (β-hCG) is an important biomarker
for the detection of ectopic pregnancies (EPs). The β-hCG levels between days 1 and 4 after …

To determine whether the change of serum β-hCG levels between Days 1 and 4 and 48-h
pre-treatment increment in β-hCG can early predict treatment failure of single-dose …

Background: The choice of methotrexate in the treatment of ectopic pregnancy depends on
the location of the ectopic mass, hemodynamic status, ultrasound findings, and the decision …

Background: Surgical management is curative for tubal ectopic pregnancy (TEP), but
multiple studies documented the safety and efficacy of single-dose methotrexate (SD-MTX) …